Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myopia
MedTech
FDA clears 1st eyeglasses for slowing childhood nearsightedness
The FDA handed a groundbreaking clearance to EssilorLuxottica and its eyeglasses to help slow the progression of nearsightedness in young children.
Conor Hale
Sep 26, 2025 11:38am
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
J&J nets new FDA approval for nearsightedness-fighting contacts
Sep 29, 2022 11:59am
Staar Surgical scopes out FDA OK for vision-correcting implant
Mar 29, 2022 10:40am
J&J tackles childhood myopia with new FDA contact lens clearance
May 12, 2021 12:32pm
J&J Vision taps Menicon in battle against myopia progression
Apr 7, 2021 11:08am
